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Abstract
Epilepsy is one of the commonest neurological problems worldwide. Approximately 3% of the
general population will suffer from epilepsy at some point in their lives. Unfortunately, indi-
viduals with epilepsy are at a higher risk of death than the general population, and sudden
unexpected death in epilepsy (SUDEP) is the most important direct epilepsy-related cause of
death. Information concerning risk factors for SUDEP is conflicting, but potential risk factors
include young age, early onset of epilepsy, duration of epilepsy, uncontrolled seizures, seizure
frequency, antiepileptic drug number and winter temperatures. Although the cause of SUDEP
is still unknown, its most commonly suggested mechanisms are cardiac abnormalities during
and between seizures. As the anatomical substrate of epileptic activity in the central nervous
system shows a direct relation to cardiovascular alterations, this may suggest that patients
with epilepsy associated with focal central nervous system lesions may face a particular risk of
SUDEP. Currently, experimental and clinical data supports the importance of specific brain
structures in the behavioural manifestation, the initiation and the propagation of seizures.
Regarding the above findings, our research group focused on this review article that SUDEP
could be related to the occurrence of specific brain structure dysfunction or anatomical change,
at least in some cases. (Cardiol J 2009; 16, 5: 394–399)
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Epilepsy: General view
The epilepsies are one of the most common
serious brain disorders, present in approximately
50 million people worldwide [1]. In the US, about
100,000 new cases per year of epilepsy are diag-
nosed [2, 3]. In the UK, between 1 in 140 and 1 in
200 people (at least 300,000 people) are currently
being treated for epilepsy [4]. Epidemiological stud-
ies suggest that 70% to 80% of the people develop-
ing epilepsy will face remission, while the remain-
ing patients will continue to have seizures and are
refractory to treatment with the currently availa-
ble therapies [5–7]. The commonest risk factors for
epilepsy are cerebrovascular disease, brain tu-
mours, alcohol, traumatic head injuries, cortical
development malformations, genetic inheritance,
and central nervous system infections. In resource-
poor countries, endemic infections such as malaria
and neurocysticercosis seem to be major risk fac-
tors [8]. Epilepsies are characterized by spontane-
ous recurrent seizures, caused by focal or general-
ized paroxysmal changes in neurological functions,
triggered by abnormal electrical activity in the cor-
tex [9]. Because it involves hyper-excitable neu-
rons, a basic assumption links the pathogenesis of
epilepsy and the generation of synchronized neu-
ronal activity to an imbalance between inhibitory
(g-aminobutyric acid [GABA]-mediated) and exci-
tatory (glutamate-mediated) neurotransmission, in
favour of the latter [10]. Seizures and epilepsy are
usually subdivided into two groups: the partial and
the generalized. The partial or focal seizures show
clinical or electroencephalogram (EEG) evidence of
a local onset and may spread to other parts of the
brain, while the generalized seizures begin simul-
taneously in both cerebral hemispheres [8].
Sudden unexpected death
in epilepsy
Introduction
Each year, around one in 1,000 patients with
chronic epilepsy die suddenly, unexpectedly, and
without explanation, even after post-mortem exami-
nation [11]. This phenomenon is called sudden un-
expected death in epilepsy (SUDEP) (Fig. 1) [11].
Thus, we have considered that epilepsy is associ-
ated with a two- to three-fold increase in mortality
when compared to the general population, and
SUDEP is the most important direct epilepsy-re-
lated cause of death [8]. Although early mortality
series reported deaths from status epilepticus were
more common at the beginning of the 20th century,
those associated with SUDEP were also recognized
[12]. Accordingly, Spratling [13] described in 1904
how epilepsy “destroys life suddenly and without
warning through a single, brief attack... and does so
in 3% to 4% of all who suffer from it”.
Definitions
The lack of autopsy findings and the rarely wit-
nessed cases of SUDEP pose difficulties in defin-
ing SUDEP. In general terms, SUDEP is defined
by the precise criteria that were approved in 1997
by an expert panel: as a sudden, unexpected, wit-
nessed or unwitnessed, non-traumatic and non-
-drowning death in patients with epilepsy, with or
without evidence of a seizure and excluding docu-
mented status epilepticus, in which post mortem
examination does not reveal a toxicological or ana-
tomical cause of death [14].
Incidence
The incidence of SUDEP varies due to differ-
ences in the population study, the documentation
Figure 1. Brain injury leads to abnormal structural and
functional reorganization of the brain circuitry. During
this time (latent period), circuitry reorganization leads
to permanent hyperexcitability and the occurrence of
recurrent spontaneous seizures. Temporal lobe epilepsy
is the most common form of drug-refractory epilepsy
and sudden unexpected death in epilepsy (SUDEP) rep-
resents the leading cause of mortality in adults with
refractory epilepsy.
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level and the SUDEP definitions [15]. Today,
SUDEP is responsible for 7.5% to 17% of all deaths
in epilepsy and has an incidence of 1:500 to 1:1,000
patient-years among adults [16].
Risk factors
The knowledge of the risk factors that under-
lie SUDEP could guide the investigations of its
pathophysiological mechanisms [17]. Likewise,
understanding those mechanisms may lead to the
identification of previously unrecognized risk fac-
tors that are more amenable to correction [17].
Currently, a number of factors associated with
SUDEP have been reported, but the results are not
entirely consistent among the studies. Those in-
clude refractoriness of the epilepsy, presence of
generalized tonic-clonic seizures, polytherapy with
antiepileptic drugs, young age, duration of the sei-
zure disorder (ranging from 15 to 20 years), early
onset of epilepsy and winter temperatures [15, 18].
Mechanisms
Understanding the mechanisms behind
SUDEP is key to its prevention [12]. Different
mechanisms are probably involved in SUDEP
when individual cases are considered [15]. Cardi-
ac mechanisms, such as repetitive cardiac damage
and arrhythmia during seizures are possibly trig-
gered by apnea and/or cerebral autonomic imbal-
ance, with sympathetic overstimulation [15, 19].
Many authors have suggested that the autonomic
nervous system (especially the sympathetic sys-
tem) may have been involved in the development
of fatal arrhythmias [19, 20]. Furthermore, unde-
tected cardiac or respiratory diseases predispos-
ing for arrhythmias or apnea may have played
a role in SUDEP [15]. Although potential patho-
mechanisms for SUDEP are unknown, it is very
likely that cardiac arrhythmia during and between
seizures play a role in this matter [15, 21].
A number of post-mortem, ictal and interictal
cardiac abnormalities account for the possibility of
seizure-induced cardiogenic SUDEP [15, 22].
Post-mortem examinations in people killed by
SUDEP have shown a more dilated and a heavier
heart than expected [15, 23, 24]. Pulmonary edema
was found in approximately 50–86% of SUDEP cas-
es [15, 23, 24]. Furthermore, some pathological al-
terations in the heart in SUDEP cases have also
been described, such as: small coronary artery wall
fibrosis, atrophy of cardiomyocytes, myofibrillar
degeneration, edema of the conductive tissue and
morphological abnormalities of the cardiac conduc-
tion system [15, 23, 24]. These abnormalities may
have been the consequence of repeated hypoxemia
and/or have been associated with the increase of
catecholamines during ictal sympathetic system
storm [15, 23, 25].
Several studies assessed the frequency and
character of ictal cardiac rhythm during seizures
[15, 22, 23, 25] and the most compelling evidence
derived from the presence of ictal arrhythmias [22].
For instance, Nashef et al. [26] recorded non-inva-
sively ictal cardiorespiratory variables in patients
with epilepsy. They found a 91% increase in the
heart rate from 41 monitored seizures, and a tran-
sient bradycardia in five seizures (four patients)
[26]. Moreover, Nei et al. [27] evaluated the elec-
trocardiographic (ECG) changes in 51 seizures from
43 patients with refractory epilepsy. They showed
that 70% of patients had either had ECG abnormali-
ties (16%) or tachycardia (30%) or both (23%)
during ictal and/or post-ictal period. The authors
suggested that those changes may have been rele-
vant to SUDEP pathophysiology [27].
Some research groups have described cardiac
investigations between seizures. Drake et al. [28]
reviewed resting ECGs from 75 patients with epi-
lepsy and compared the ventricular rate, the PR in-
terval, the QRS duration and the QT interval correct-
ed for heart rate (QTc) with the normal ECGs re-
corded from age-matched patients without cardiac or
neurological disorders. Epilepsy patients showed
a higher heart rate and a longer QT duration than
those from ECG recorded age-matched patients
without a cardiac or neurological disorder. However,
heart rate and QT duration were not outside the nor-
mal range [28]. In 2003, Tigaran et al. [29] investigat-
ed whether patients with drug refractory epilepsy had
cardiovascular abnormalities that might have been
related to a high frequency of sudden death. In their
study, 23 subjects underwent comprehensive cardio-
vascular evaluations (ECG, Holter-monitoring,
echocardiography, ergometric exercise test, myocar-
dial scintigraphy and coronary angiography, whenever
abnormalities were found) before and during video-
-EEG monitoring. They found a ST-segment depres-
sion in 40% of the cases associated with a higher maxi-
mum heart rate during seizures, suggesting that a car-
diac ischemia may have occurred in those patients [29].
Although interictal changes in heart rate variability
have been described in patients with epilepsy, their
contribution to SUDEP remains to be determined.
The role of brain-heart connection
Elucidating risk factors and establishing
SUDEP mechanisms are very important in deve-
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loping prevention methods. Of the many risk factors
suggested for SUDEP, cerebral mechanisms or
transmission of epileptic activity via the autonomic
nervous system to the heart, play an interesting role
in this scenario. An increase in the sympathetic
nervous discharge leads to increased secretion of
adreno-medullary catecholamines and to reduced
parasympathetic activity, facilitating the occurrence
of supraventricular and ventricular arrhythmias that
are observed in cerebrogenic diseases [19].
It has long been believed that in the healthy
brain the stimulation or the lesion of some central
nervous system structures is able to promote mor-
phological and functional cardiovascular alterations
[30]. As the anatomical substrate of epileptic acti-
vity in the central nervous system shows a direct
relation to cardiovascular alterations, this may sug-
gest that patients with epilepsy associated with
focal central nervous system lesions may be at par-
ticular risk of SUDEP [30, 31]. It has been shown
that epileptic activity originating in some brain
structures (amygdala, cingulated gyrus, insular cor-
tex, frontopolar or frontoorbital regions) may have
induced arrhythmias such as supraventricular tach-
ycardia, sinus tachycardia, sinus bradycardia, sinus
arrest, atrioventricular block and asystole [22, 32],
which could have been implicated in SUDEP. In this
respect, it was also shown that electrical stimula-
tion of the pre-central operculum proved to elicit
apnea in patients with epilepsy, whereas insults to
the insular cortex appeared to promote cerebrogen-
ic sudden death [22, 33, 34]. Furthermore, it is also
interesting to note that despite the clear indications
that the insular cortex regulates cardiovascular
function in animals and humans, little data is avail-
able regarding its implication in severe ictal arrhyth-
mias or SUDEP occurrence [22, 35, 36]. Willing to
find the specific brain structures related to the car-
diovascular abnormalities and hence SUDEP occur-
rence in patients with refractory epilepsy, our re-
search group was the first to propose a possible role
of the thalamus in some cases of SUDEP [37].
A possible role of thalamic nuclei in triggering
and spreading epileptic discharges has been dis-
cussed over the last four decades [38], and current
experimental and clinical data supports an impor-
tant role for thalamic nuclei in the behavioural man-
ifestations, the initiation and the propagation of
epileptic seizures [39]. The importance of the tha-
lamus in the genesis of epileptic seizures is related
to its extensive projection to the cortex and to oth-
er areas, including the basal ganglia, cerebellum,
and hippocampus [40, 41]. Though temporal lobe
epilepsy (TLE) is the commonest form of partial
epilepsy, and hippocampal atrophy and sclerosis are
the most frequent abnormalities associated with
TLE, brain structural changes in patients with TLE
are not confined solely to the hippocampus. Indeed,
they have been reported to occur in other brain
regions, such as the parahippocampal region, entorhi-
nal and perirhinal cortex [42–44]. Interestingly,
a recent study has demonstrated thalamic atrophy in
patients with TLE, which was more prominent in the
thalamic nuclei that had strong connections with the
limbic system [45]. Moreover, using the pilocarpine
model of TLE, our research group also reported an
important role of the posterior thalamus in the cere-
bral circuits of rats with epilepsy [46]. The first study
investigated the interictal cerebral metabolic rate with
14C-2DG autoradiography in chronic pilocarpine-
-induced rats and found an increase in the glucose uti-
lization by several brain regions in epilepsy [47]. The
most relevant finding was that of a consistent rise of
cerebral metabolic rate in the lateral posterior (LP)
thalamic nuclei, suggesting that the LP may have been
involved in the cerebral circuitry controlling epilep-
tic activity during interictal intervals. The second
study evaluated the contribution of LP to spontane-
ous recurrent seizure activity induced by pilocarpine
[46]. It was shown there that bilateral LP lesion by
ibotenic acid in chronic epileptic rats resulted in an
increase of seizure frequency, suggesting that LP was
one of the most important thalamic nuclei involved in
the inhibition of spreading mechanisms.
In accordance with the above-mentioned find-
ings, is it plausible to propose that cardiovascular
abnormalities, and hence SUDEP, could be related
to the occurrence of lateral posterior thalamic mor-
phological or functional changes, at least in some
cases? As research in this field must be guided by
the possible mechanism of SUDEP, a number of
arguments might be put forward. From the morpho-
logical point of view, Boyko et al. [48] showed that
bilateral injections of kainic acid into the thalamus,
mainly in the lateral posterior thalamic nuclei, pro-
duced myocardial necrosis in adult rats, suggesting
that this specific thalamic nucleus was directly re-
lated to the cardiovascular system. In the same way,
it is very important to establish whether there is
a relation between the lateral posterior thalamic nu-
clei dysfunction and the cardiac functioning. Accord-
ing to this, an experimental study developed by our
group may have started to reinforce this idea. In
2005, we evaluated the in vivo heart rate (ECG) and
isolated the ex vivo preparation (Langendorf prepa-
ration) of rats with epilepsy [49]. Our results
showed significant differences in the in vivo mean
heart rate from the groups (control animals: 307 ±
398
Cardiology Journal 2009, Vol. 16, No. 5
www.cardiologyjournal.org
± 9 bpm, and animals with epilepsy: 346 ± 7 bpm).
In contrast, we did not find differences during iso-
lated ex vivo situation (control animals: 175 ± 7 bpm,
and animals with epilepsy: 176 ± 6 bpm), suggest-
ing a central nervous system modulation on the heart
(such as the thalamic nucleus), which could explain
sudden unexpected death in epilepsy. Quite inter-
estingly and more recently, our group (Scorza et al.,
unpublished data) evaluated the heart rate (in vivo
and isolated ex vivo) of rats with epilepsy before and
after bilateral LP lesion. The results showed signifi-
cant differences in the in vivo mean heart rate but,
surprisingly, no differences in the heart rate could be
observed in the isolated ex vivo situation. These ob-
servations seem to indicate a certain kind of specific
thalamic modulation over the heart functioning, which
could support our hypothesis of SUDEP due to heart
failure as a consequence of thalamic dysfunction.
Neurocardiology has many dimensions [50],
and we believe that the brain’s effects on the heart
are the most fascinating areas of research. To date,
there is clear evidence suggesting that the cere-
bral mechanisms or the overactivity of the auto-
nomic nervous system’s sympathetic limb is the
common phenomenon that links the major cardio-
vascular abnormalities seen in neurological disor-
ders [50], including epilepsy. Thus, the presence
of thalamic nuclei lesions in people with TLE could
underlie some processes that culminate in SUDEP,
and heart failure could play a significant role in this
mechanism (Fig. 2).
Finally, we would like to emphasize that a clear
relationship between TLE, thalamic dysfunction,
heart failure and SUDEP still needs to be demon-
strated both under experimental and human condi-
tions. In the meantime, strategies such as taking
a detailed cardiovascular history, looking for cardi-
ovascular co-morbidity, evaluating cardiovascular
risk factors and prior abnormal cardiac findings
(electrocardiogram and echocardiogram) should be
developed in an attempt to prevent SUDEP.
Conclusions
SUDEP is the most important direct epilepsy-
related cause of death and a number of its associat-
ed factors have been proposed. Mechanisms of
SUDEP occurrence are still unclear and brain-heart
connections may play an important role in the de-
velopment of seizure-related and potentially fatal
cardiac arrhythmias. The direct and indirect effects
of some brain structures in the cardiac rhythm still
need more elucidation. In the meantime, epilepto-
logists should pay careful attention to the presence
of cardiovascular associated diseases, especially in
patients with associated potential SUDEP risk
factors.
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